RT @cvirendo: #SundayRead "Fast introductions and short-term follow-ups do not only contain safety risks, but also hold the risk of losing…
#SundayRead "Fast introductions and short-term follow-ups do not only contain safety risks, but also hold the risk of losing focus on the clinical goals for the new technologies." Read Editor-in-Chief Prof. Reekers' full editorial #throwback #IRad https:
@K_Stavroulakis @conceptmedicals @Dr_Bisdas @FadiSaab17 @a_saratzis @EndovascularU @Vascupedia_com @kmadass @HadyLichaaMD Congratulations! It looks very promising! Everytime it looks that there's some new "panacea" on the market I always suggest this paper
RT @SimonNeequaye: This applies to more than just vascular/ #IR . It’s a problem for medicine/surgery and reflects reward structures for in…
RT @SimonNeequaye: This applies to more than just vascular/ #IR . It’s a problem for medicine/surgery and reflects reward structures for in…
RT @SimonNeequaye: This applies to more than just vascular/ #IR . It’s a problem for medicine/surgery and reflects reward structures for in…
"Doctors should be doctors. ....Secondly, a more rigid post-market surveillance with an early warning system should be installed for all new IR technologies. "
This applies to more than just vascular/ #IR . It’s a problem for medicine/surgery and reflects reward structures for innovation/front running. For the times they are a-changin’? https://t.co/Iu4MCuKPIS @CVIR_Journal @BSETnews @VSGBI @BJSurgery @BSIR_News
RT @cvirendo: For the times they are a-changin’? | CVIR Endovascular | Full Text . FDA is now also looking into IR. Self-cleaning is always…
RT @cvirendo: For the times they are a-changin’? | CVIR Endovascular | Full Text . FDA is now also looking into IR. Self-cleaning is always…
RT @cvirendo: For the times they are a-changin’? | CVIR Endovascular | Full Text . FDA is now also looking into IR. Self-cleaning is always…
RT @cvirendo: For the times they are a-changin’? | CVIR Endovascular | Full Text . FDA is now also looking into IR. Self-cleaning is always…
For the times they are a-changin’? | CVIR Endovascular | Full Text . FDA is now also looking into IR. Self-cleaning is always the best methode for damage control. IR should be pro-active in handling these problems. For the future of IR. https://t.co/RJIkk
Lesson here for all physicians adopting new technology. Focus on the patient in front of you. Be skeptical when it comes to new technology. If you see unexpected problems, don’t be afraid to ask why? Look after your data so you can respond to concerns @BSE
RT @Stierbeker: Lees dit stuk! Uit de interventieradiologie, maar dit is ook ontzettend waar voor zoveel andere vakgebieden. https://t.co/n…
Lees dit stuk! Uit de interventieradiologie, maar dit is ook ontzettend waar voor zoveel andere vakgebieden.
For the times they are a-changin’? https://t.co/vWM18qmFEj
Come, doctors and scientists who prophesise with your pen, and keep your eyes wide – the chance won’t come again! 👩⚕️ 👨🏽⚕️ #BobDylan https://t.co/iZjV512s6u
What can we learn as #interventionalists? First of all, we should start to put the #patient in the focus of our attention again – not only his lesion. #Doctors should be doctors 👩⚕️ 👨🏽⚕️ @SIRspecialists @cirsesociety https://t.co/iZjV512s6u
@US_FDA 510(k) clearance system, where new technologies are rapidly introduced based on comparisons with related recently introduced technologies, which are often also not well evaluated. It looks a little like a #Ponzi scheme. #HealthTech #Medicaldevices
RT @DrMarcBailey: An excellent view. https://t.co/BcToFvApmW
RT @davebosanquet: For the times they are a-changin’? https://t.co/YjdsRC6xwK #
For the times they are a-changin’? https://t.co/YjdsRC6xwK #
For the times they are a-changin’? | CVIR Endovascular | Full Text https://t.co/cBTjXMUXHg
An excellent view.
RT @AniMirakhurMD: A useful read for all interventionalists! #PatientFirst @CAIRads @SIRRFS @SIRspecialists https://t.co/hzbSQtGPCD #
RT @AniMirakhurMD: A useful read for all interventionalists! #PatientFirst @CAIRads @SIRRFS @SIRspecialists https://t.co/hzbSQtGPCD #
RT @cvirendo: For the times they are a-changin’? | CVIR Endovascular | Full Text https://t.co/RJIkkpSay3
RT @AniMirakhurMD: A useful read for all interventionalists! #PatientFirst @CAIRads @SIRRFS @SIRspecialists https://t.co/hzbSQtGPCD #
A useful read for all interventionalists! #PatientFirst @CAIRads @SIRRFS @SIRspecialists https://t.co/hzbSQtGPCD #
Well said Greg!
Excellent and thought provoking article; particularly elegant analysis of TLR and IMPERIAL trial. Remember the basics of #HippocraticOath #firstdonoharm https://t.co/a99ysPmc4q
RT @mo_hamady: A good paper by JK as always! Two important comments thu; in assessing new tech, we should find the balance between doing th…
RT @GregMakris23: "What can we learn as interventionalists? First of all, we should start to put the patient in the focus of our attention…
A good paper by JK as always! Two important comments thu; in assessing new tech, we should find the balance between doing the right thing vs “overdoing” it & 2nd encourage everybody( vs, cardio, etc) to do the same@BSIR_News#IRad@CIRSE
RT @GregMakris23: "What can we learn as interventionalists? First of all, we should start to put the patient in the focus of our attention…
RT @GregMakris23: "What can we learn as interventionalists? First of all, we should start to put the patient in the focus of our attention…
"What can we learn as interventionalists? First of all, we should start to put the patient in the focus of our attention again – not only his lesion. Doctors should be doctors. "so true ...@cvirendo @cirsesociety @BSIR_News https://t.co/D4WbuIPyMA
RT @cvirendo: For the times they are a-changin’? | CVIR Endovascular | Full Text https://t.co/RJIkkpSay3
For the times they are a-changin’? | CVIR Endovascular | Full Text https://t.co/RJIkkpSay3